DEUTSCHE BANK AG\ - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 20 filers reported holding LEAP THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$248,000
-81.3%
124,338
-27.1%
0.00%
Q3 2018$1,329,000
-7.4%
170,676
+7.0%
0.00%
Q2 2018$1,435,000
+150.9%
159,476
+131.4%
0.00%
Q1 2018$572,000
+1261.9%
68,921
+913.5%
0.00%
Q4 2017$42,0006,800
+48471.4%
0.00%
Q1 2017$0140.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
M28 Capital Management LP 1,000,000$3,240,0002.53%
Ally Bridge Group (NY) LLC 1,815,000$5,881,0002.06%
TANG CAPITAL MANAGEMENT LLC 2,500,000$8,100,0001.63%
Ghost Tree Capital, LLC 1,350,000$4,374,0001.57%
Key Client Fiduciary Advisors, LLC 508,980$1,649,0001.36%
SILVERARC CAPITAL MANAGEMENT, LLC 1,013,664$3,284,0001.33%
ACT CAPITAL MANAGEMENT, LLC 225,000$729,0000.53%
Sio Capital Management, LLC 440,000$1,426,0000.43%
Perceptive Advisors 16,952,992$54,926,0000.42%
Artal Group S.A. 4,000,000$12,960,0000.35%
View complete list of LEAP THERAPEUTICS INC shareholders